Finance
Monitor maker reports higher first-quarter results
Published in Medical Devices and Surgical Technology Week, November 28th, 2004
Earnings per diluted share were 31 cents versus 28 cents last year. Sales for the quarter increased 4% to $80.3 million from $77.1 million last year, with foreign exchange contributing $1.2 million of the increase.
The increase in first-quarter earnings was primarily attributable to increased sales and a higher gross profit margin. Research and development expenses increased 20% to $8.6 million in the first quarter this year compared to $7.2 million last year, reflecting the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Allergic Rhinitis
Intranasal irradiation with XeCl UVB laser ameliorates symptoms - Cancer Immunology
Phage-based microarrays useful for humoral immune analysis - Drug Development
Ultrafast analytical method developed for high-throughput parallel synthesis - Enzymology
Novel immunoassay facilitates cytochrome P450 quantification - Immunology
Novel assay provides simultaneous measure of serum and PBMC cytokines - Acute Myelogenous Leukemia
Phenotypic karyotype markers identified in AML with t(8;21) - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
